SCHEMBL2396951

SCHEMBL2396951

CCCCOC(=O)C=CC=Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.59
ATM Q13315 1/20 0.54
KDM4E B2RXH2 2/20 0.54
APP P05067 5/20 0.53
HCAR2 Q8TDS4 2/20 0.53
AKR1B10 O60218 2/20 0.52
AKR1B1 P15121 2/20 0.52
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877957 0.91 AKR1B10 (0.55) TDP1APPHCAR2AKR1B10AKR1B1
SCHEMBL5875714 0.90 TDP1 (0.53) TDP1ATMKDM4EAPPHCAR2
Butyl Cinnamate SCHEMBL119510 0.89 APP (0.65) TDP1ATMAPPHCAR2AKR1B10
Butyl Cinnamate SCHEMBL119511 0.89 APP (0.65) TDP1ATMAPPHCAR2AKR1B10
Butyl Cinnamate SCHEMBL5314386 0.89 APP (0.65) TDP1ATMAPPHCAR2AKR1B10
SCHEMBL30023403 0.87 TSHR (0.63) TDP1ATMKDM4EAPPHCAR2
Juarezic Acid SCHEMBL8887961 0.87 TSHR (0.55) TDP1ATMKDM4EAPPHCAR2
Juarezic Acid SCHEMBL1627203 0.87 TSHR (0.55) TDP1ATMKDM4EAPPHCAR2
SCHEMBL29975936 0.86 APP (0.54) TDP1ATMAPPHCAR2LMNA
SCHEMBL22881958 0.85 AKR1B10 (0.52) TDP1APPAKR1B10AKR1B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026196-B2 Delayed-effect agronomic treatment agent, in particular for seed germination and plant development CLAUSE (FR) 2011-09-27 US claimed
US-20090199314-A1 DELAYED-EFFECT AGRONOMIC TREATMENT AGENT, IN PARTICULAR FOR SEED GERMINATION AND PLANT DEVELOPMENT CLAUSE TEZIER (FR) 2009-08-06 US claimed
EP-4163277-B1 NOVEL PYRAZOLE DERIVATIVES APTABIO THERAPEUTICS INC (KR) 2026-01-14 EP disclosed
EP-4501920-A1 NOVEL PYRAZOLE DERIVATIVES Aptabio Therapeutics Inc. (KR) 2025-02-05 EP disclosed
US-20240308983-A1 NOVEL PYRAZOLE DERIVATIVES APTABIO THERAPEUTICS INC (KR) 2024-09-19 US disclosed
US-11999718-B2 Pyrazole derivatives APTABIO THERAPEUTICS INC. (KR) 2024-06-04 US disclosed
US-20230234940-A1 NOVEL PYRAZOLE DERIVATIVES APTABIO THERAPEUTICS INC. (KR) 2023-07-27 US disclosed
EP-4163277-A1 NOVEL PYRAZOLE DERIVATIVES Aptabio Therapeutics Inc. (KR) 2023-04-12 EP disclosed
CN-115073294-A Method for synthesizing axial chiral aryl conjugated diene through asymmetric alfa-C-H olefination reaction and product thereof 杭州师范大学 2022-09-20 CN disclosed
CN-105330780-B A kind of styrene base resin porous material of adsorbable polycyclic aromatic hydrocarbon and preparation method thereof 同济大学 2018-06-05 CN disclosed
US-8026196-B2 Delayed-effect agronomic treatment agent, in particular for seed germination and plant development CLAUSE (FR) 2011-09-27 US disclosed
US-20090199314-A1 DELAYED-EFFECT AGRONOMIC TREATMENT AGENT, IN PARTICULAR FOR SEED GERMINATION AND PLANT DEVELOPMENT CLAUSE TEZIER (FR) 2009-08-06 US disclosed
US-20090175515-A1 METHOD, DEVICE, AND COMPUTER PROGRAMME FOR EVALUATING IMAGES OF A CAVITY TOMTEC IMAGING SYSTEMS GMBH (DE) 2009-07-09 US disclosed
US-5356660-A Method for obtaining composite conductive materials based on conductive polymers, with controlled dielectrical properties THOMSON-CSF (FR) 1994-10-18 US disclosed
US-5104580-A CONDUCTIVE COMPOSITE POLYMER FILM AND METHOD FOR ITS MANUFACTURE THOMSON-CSF (FR) 1992-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11999718-B2 Pyrazole derivatives CYP11B1, CYP11B2, CYP3A43 TDP1 1482/4885ATM 3063/4885KDM4E 3939/4885
US-20230234940-A1 NOVEL PYRAZOLE DERIVATIVES CYP4B1, CYP3A43, CYP11B1 TDP1 1501/4885ATM 2945/4885KDM4E 4060/4885
US-20240308983-A1 NOVEL PYRAZOLE DERIVATIVES CYP4B1, CYP3A43, CYP11B1 TDP1 1501/4885ATM 2945/4885KDM4E 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.